Los puntos clave no están disponibles para este artículo en este momento.
Chondrocyte mechanotransduction dysfunction is a key feature of osteoarthritis (OA). Previous studies have demonstrated that primary cilia play a crucial role in chondrocyte mechanosensation and signal transduction. Transient Receptor Potential Vanilloid 4 (TRPV4), which is highly expressed on primary cilia, is a critical mechanotransduction protein and one of the most important Ca 2+ channels. However, the interplay between the mechanism of primary cilia-mediated signaling and that of TRPV4 channel regulation remains poorly understood. Here, we demonstrate that OA chondrocytes and Intraflagellar Transport Protein 88 (Ift88) conditional knockout (cKO) mice exhibit reduced ciliary incidence resulting in cartilage degeneration. TRPV4 expression inversely correlated with ciliary integrity, increasing as cilia were lost. In cilia-intact healthy chondrocytes, TRPV4 antagonism inhibited Ca 2+ -dependent NF-κB activation while promoting type II collagen (COL2) synthesis. These effects were abolished by Interleukin-1 beta (IL-1β)-induced ciliary defect or IFT88 deficiency. Chromatin immunoprecipitation (ChIP) analysis revealed disrupted p65 binding to the COL2 promoter upon the loss of ciliary integrity. Crucially, Ift88 cKO chondrocytes showed unresponsiveness of the TRPV4 channel, as confirmed by Ca 2+ flux and changes in the expression levels of NF-κB and COL2. Our findings position primary cilia as indispensable regulators of TRPV4-mediated NF-κB - COL2 signaling, offering mechanistic insights into OA pathogenesis and identifying IFT88 as a therapeutic checkpoint. • Ciliary defect promotes the onset and progression of osteoarthritis. • TRPV4 antagonism suppresses Ca 2+ influx and NF-κB activation while enhancing COL2 synthesis in healthy chondrocytes. • Ciliary defect upregulates TRPV4 expression, yet results in TRPV4 channel dysfunction. • Primary cilia integrity governs the TRPV4/Ca 2+ − NF-κB - COL2 signaling axis.
Sun et al. (Mon,) studied this question.